Every material Form 8-K ScanSource filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
At its December 10, 2024 annual meeting, ScanSource shareholders approved the 2024 Omnibus Incentive Compensation Plan, which replaces the 2021 plan for future grants. All eight director nominees were elected, and shareholders also approved the advisory say-on-pay vote and ratified Grant Thornton LLP as auditors for fiscal 2025.
2024 Plan reserves 2,234,543 shares of common stock for awards, plus shares from 2021 Plan awards that later become available
No further awards will be granted under the 2021 Plan; outstanding 2021 awards continue under their terms
Plan approval received 19,590,961 for votes and 1,215,191 against votes
Shareholders represented by proxy held 89.5% of outstanding common stock, or 21,501,384 shares
ScanSource reported fiscal first-quarter 2025 results for the quarter ended September 30, 2024, with net sales down 11.5% to $775.6 million and GAAP diluted EPS up 13.1% to $0.69. GAAP operating income fell 26.8% to $17.6 million, and the company reaffirmed its fiscal 2025 annual outlook without change. For shareholders, per-share profit rose on lower sales, while the sales decline and operating income drop show a weaker underlying operating trend.
Net sales were $775.6 million, down 11.5% year over year; non-GAAP net sales, excluding currency and acquisitions, fell 10.7%.
GAAP diluted EPS was $0.69 versus $0.61; non-GAAP diluted EPS was $0.84 versus $0.74.
GAAP operating income was $17.6 million versus $24.1 million, including $5.1 million in restructuring and other charges.
Fiscal 2025 outlook was reaffirmed: net sales $3.1 billion to $3.5 billion, adjusted EBITDA $140 million to $160 million, and free cash flow of at least $70 million.
ScanSource reported fourth-quarter and fiscal 2024 results for the year ended June 30, 2024, with net sales down 21.2% in the quarter and 13.9% for the year, and GAAP diluted EPS down year over year. The company also issued its first fiscal 2025 outlook, projecting net sales of $3.1 billion to $3.5 billion and adjusted EBITDA of $140 million to $160 million, and said it completed two acquisitions in August 2024.
Q4 fiscal 2024 net sales were $746.1 million, down 21.2%, and GAAP diluted EPS was $0.64 versus $0.68 a year earlier.
Fiscal 2024 GAAP diluted EPS was $3.06 versus $3.47, and operating cash flow was $371.6 million versus a $35.8 million outflow.
FY25 outlook: net sales $3.1 billion to $3.5 billion, adjusted EBITDA $140 million to $160 million, and free cash flow of at least $70 million.
ScanSource reported third-quarter fiscal 2024 net sales of $752.6 million, down 15.0% year over year, and GAAP diluted EPS of $0.50, down from $0.83. The company lowered its full-year fiscal 2024 guidance for net sales, adjusted EBITDA and free cash flow was raised, and it announced a new $100 million share repurchase authorization.
Q3 net sales $752.6 million, down 15.0%; GAAP net income $12.8 million, down 39.7%
FY24 net sales outlook cut to at least $3.3 billion from at least $3.5 billion; adjusted EBITDA cut to at least $140 million from at least $155 million
FY24 free cash flow outlook raised to at least $275 million from at least $200 million
New $100 million share repurchase authorization; about $45 million remained under the prior authorization as of March 31, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every ScanSource filing is on SEC EDGAR ↗. 8-K briefs of other companies →